Hesperidin, a flavonoid glycoside with sedative effect, decreases brain pERK1/2 levels in mice

Pharmacology Biochemistry and Behavior

Volumn 92, Issue 2, 2009, Pages 291-296

  Martínez, M Cecilia ^a   Fernandez, Sebastian P ^a   Loscalzo, Leonardo M ^a   Wasowski, Cristina ^a   Paladini, Alejandro C ^a   Marder, Mariel ^a   Medina, Jorge H ^a   Viola, Haydée ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Hesperidin; Mouse; p CaMKII; pERK 1 2; Sedation

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II ALPHA; DRUG VEHICLE; FLAVONOID GLYCOSIDE; HESPERIDIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEOHESPERIDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; INTRACELLULAR TRANSPORT; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEDATION;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; HESPERIDIN; HYPNOTICS AND SEDATIVES; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

MUS;

EID: 59749100749     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.12.016     Document Type: Article

References (42)

1. Abou-Shoer M., Ma G.E., Li X.H., Koonchanok N.M., Geahlen R.L., and Chang C.J. Flavonoids from Koelreuteria henryi and other sources as protein-tyrosine kinase inhibitors. J Nat Prod 56 (1993) 967-969
2. Agullo G., Gamet-Payrastre L., Manenti S., Viala C., Remesy C., Chap H., et al. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53 (1997) 1649-1657
3. Ailing F., Fan L., Li S., and Manji S. Role of extracellular signal-regulated kinase signal transduction pathway in anxiety. J Psychiatr Res (2008)
4. Cammarota M., Bevilaqua L.R., Ardenghi P., Paratcha G., Levi de Stein M., Izquierdo I., et al. Learning-associated activation of nuclear MAPK, CREB and Elk-1, along with Fos production, in the rat hippocampus after a one-trial avoidance learning: abolition by NMDA receptor blockade. Brain Res Mol Brain Res 76 (2000) 36-46
5. Chang B.H., Mukherji S., and Soderling T.R. Calcium/calmodulin-dependent protein kinase II inhibitor protein: localization of isoforms in rat brain. Neuroscience 102 (2001) 767-777
6. Chung J.Y., Park J.O., Phyu H., Dong Z., and Yang C.S. Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3,3'-digallate. Faseb J 15 (2001) 2022-2024
7. Dietz B.M., Mahady G.B., Pauli G.F., and Farnsworth N.R. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res Mol Brain Res 138 (2005) 191-197
8. Eitan S., Bryant C.D., Saliminejad N., Yang Y.C., Vojdani E., Keith Jr. D., et al. Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization. J Neurosci 23 (2003) 8360-8369
9. Fernandez S.P., Wasowski C., Paladini A.C., and Marder M. Synergistic interaction between hesperidin, a natural flavonoid, and diazepam. Eur J Pharmacol 512 (2005) 189-198
10. Fernandez S.P., Wasowski C., Loscalzo L.M., Granger R.E., Johnston G.A., Paladini A.C., et al. Central nervous system depressant action of flavonoid glycosides. Eur J Pharmacol 539 (2006) 168-176
11. File S.E., and Pellow S. The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard. Br J Pharmacol 86 (1985) 729-735
12. Gutstein H.B., Rubie E.A., Mansour A., Akil H., and Woodgett J.R. Opioid effects on mitogen-activated protein kinase signaling cascades. Anesthesiology 87 (1997) 1118-1126
13. Hagiwara M., Inoue S., Tanaka T., Nunoki K., Ito M., and Hidaka H. Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases. Biochem Pharmacol 37 (1988) 2987-2992
14. Houghton P.J. The scientific basis for the reputed activity of Valerian. J Pharm Pharmacol 51 (1999) 505-512
15. Hwang S.L., and Yen G.C. Neuroprotective effects of the citrus flavanones against H2O2-induced cytotoxicity in PC12 cells. J Agric Food Chem 56 (2008) 859-864
16. Kalluri H.S., and Ticku M.K. Role of GABA(A) receptors in the ethanol-mediated inhibition of extracellular signal-regulated kinase. Eur J Pharmacol 451 (2002) 51-54
17. Kalluri H.S., and Ticku M.K. Ethanol-mediated inhibition of mitogen-activated protein kinase phosphorylation in mouse brain. Eur J Pharmacol 439 (2002) 53-58
18. Khan N., Afaq F., Saleem M., Ahmad N., and Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 66 (2006) 2500-2505
19. Kobuchi H., Roy S., Sen C.K., Nguyen H.G., and Packer L. Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am J Physiol 277 (1999) C403-411
20. Loscalzo L.M., Wasowski C., Paladini A.C., and Marder M. Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines. Eur J Pharmacol 580 (2008) 306-313
21. Marder M., Viola H., Wasowski C., Fernandez S., Medina J.H., and Paladini A.C. 6-methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS. Pharmacol Biochem Behav 75 (2003) 537-545
22. Medina J.H., Pena C., Levi de Stein M., Wolfman C., and Paladini A. Benzodiazepine-like molecules as well as other ligands from the brain for the brain benzodiazepine receptor are relatively common constituents of plants. Biochem Biophys Res Commun 165 (1998) 547-555
23. Morozov A., Muzzio I.A., Bourtchouladze R., Van-Strien N., Lapidus K., Yin D., et al. Rap1 couples cAMP signaling to a distinct pool of p42/44MAPK regulating excitability, synaptic plasticity, learning, and memory. Neuron 39 (2003) 309-325
24. Neuhaus T., Pabst S., Stier S., Weber A.A., Schror K., Sachinidis A., et al. Inhibition of the vascular-endothelial growth factor-induced intracellular signaling and mitogenesis of human endothelial cells by epigallocatechin-3 gallate. Eur J Pharmacol 483 (2004) 223-227
25. Rainey-Smith S., Schroetke L.W., Bahia P., Fahmi A., Skilton R., Spencer J.P., et al. Neuroprotective effects of hesperetin in mouse primary neurones are independent of CREB activation. Neurosci Lett 438 (2008) 29-33
26. Reynolds J. Martindale: the extra pharmacopeia. 31st edition (1996), The Pharmaceutical Press, London
27. Sah J.F., Balasubramanian S., Eckert R.L., and Rorke E.A. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem 279 (2004) 12755-12762
28. Schroeter H., Boyd C., Spencer J.P., Williams R.J., Cadenas E., and Rice-Evans C. MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol Aging 23 (2002) 861-880
29. Schulz S., and Hollt V. Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine-dependent rats in vivo. Eur J Neurosci 10 (1998) 1196-1201
30. Serra H., Mendes T., Bronze M.R., and Simplicio A.L. Prediction of intestinal absorption and metabolism of pharmacologically active flavones and flavanones. Bioorg Med Chem 16 (2008) 4009-4018
31. Spencer J.P., Rice-Evans C., and Williams R.J. Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 278 (2003) 34783-34793
32. Sweatt J.D. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76 (2001) 1-10
33. Thomas G.M., and Huganir R.L. MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 5 (2004) 173-183
34. Valjent E., Pages C., Herve D., Girault J.A., and Caboche J. Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 19 (2004) 1826-1836
35. Vauzour D., Vafeiadou K., Rice-Evans C., Williams R.J., and Spencer J.P. Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J Neurochem 103 (2007) 1355-1367
36. Vignes M., Maurice T., Lante F., Nedjar M., Thethi K., Guiramand J., et al. Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG). Brain Res 1110 (2006) 102-115
37. Viola H., Wolfman C., Levi de Stein M., Wasowski C., Pena C., Medina J.H., et al. Isolation of pharmacologically active benzodiazepine receptor ligands from Tilia tomentosa (Tiliaceae). J Ethnopharmacol 44 (1994) 47-53
38. Viola H., Wasowski C., Levi de Stein M., Wolfman C., Silveira R., Dajas F., et al. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Med 61 (1995) 213-216
39. Viola H., Wasowski C., Marder M., Wolfman C., Paladini A., and Medina J.H. Sedative and hypnotic properties of Salvia guaranitica St. Hil. and of its active principle, cirsiliol. Phytomedicine 4 (1997) 45-50
40. Wasowski C., Marder M., Viola H., Medina J.H., and Paladini A.C. Isolation and identification of 6-methylapigenin, a competitive ligand for the brain GABA(A) receptors, from Valeriana wallichii. Planta Med 68 (2002) 934-936
41. Wolfman C., Viola H., Paladini A., Dajas F., and Medina J.H. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol Biochem Behav 47 (1994) 1-4
42. Youdim K.A., Dobbie M.S., Kuhnle G., Proteggente A.R., Abbott N.J., and Rice-Evans C. Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem 85 (2003) 180-192